GMED Earnings

GMED reported its FY2025Q4 earnings on 2026-02-24, showcasing a revenue of against an estimate of 769.40M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 1.06 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following GMED's FY2025Q4 earnings announcement on 2026-02-24, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, GMED's stock price tends to shift by an average of +1.86% in the 10 days leading up to earnings and +6.13% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate GMED’s annual revenue to reach 778.31M, while the EPS is projected at 1.09. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.03% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between GMED's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -0.03%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, GMED's stock price typically moves by +1.86% in the 10 days before its earnings and +6.13% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 1.09 and revenue of 778.31M.

The earnings call reveals strong financial performance, product development, and market strategy, with positive growth in revenue and free cash flow. The Q&A highlights optimism in AI integration and market expansion, despite some uncertainties in monetization guidance. The reaffirmed revenue guidance and robust pipeline support a positive sentiment. The lack of specific guidance on certain metrics is a minor concern, but overall, the company's strategic initiatives and operational improvements suggest a positive outlook.